Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Whistle-Stop Tour of 2017 – From An EU Regulatory Point Of View

Executive Summary

This past year was a busy one for regulators and regulated alike in the EU. We take a look at some of the key events from 2017.

You may also be interested in...

Pharma Struggling To Assimilate Flood Of Clinical Trial Data

Big data may be prolonging development times for new pharmaceuticals, as companies struggle to cope with diverse digital applications and clinical trial protocol changes.

EMA Ends Year With Set of Straight Noes For PRIME Applicants

The European Medicines Agency rejected all seven eligibility requests for its priority medicines scheme that it reviewed in December.

Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users

After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts